The rise of Viagra and its effect on the pharmaceutical landscape presents a complex question for traders. While the early sales statistics were impressive, the patent has expired, leading to a flood of generic alternatives that are eroding revenue. Furthermore, the industry is facing difficulties related to aging trends and shifting healthcare gui